Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
BACTI-B.ST Stock Summary
In the News
BACTI-B.ST Financial details
Company Rating
Neutral
Market Cap
2.56B
Income
-138.38M
Revenue
218.09M
Book val./share
10.08
Cash/share
3.52
Dividend
-
Dividend %
-
Employees
205
Optionable
No
Shortable
Yes
Earnings
25 Apr 2024
P/E
-18.59
Forward P/E
516.43
PEG
-1.15
P/S
11.37
P/B
6.08
P/C
20.54
P/FCF
-39.83
Quick Ratio
1.43
Current Ratio
2.55
Debt / Equity
0.54
LT Debt / Equity
-
-
-
EPS (TTM)
-3.95
EPS next Y
0.14
EPS next Q
-0.67
EPS this Y
161.59%
EPS next Y
-103.54%
EPS next 5Y
-136.71%
EPS last 5Y
NAN%
Revenue last 5Y
1.73%
Revenue Q/Q
13.67%
EPS Q/Q
11.43%
-
-
-
-
SMA20
-4.04%
SMA50
1.37%
SMA100
19.3%
Inst Own
-
Inst Trans
-
ROA
-18%
ROE
-28%
ROC
-0.21%
Gross Margin
70%
Oper. Margin
-64%
Profit Margin
-61%
Payout
-
Shs Outstand
34.66M
Shs Float
20.79M
-
-
-
-
Target Price
-
52W Range
49.5-95.0
52W High
-23.89%
52W Low
+47.55%
RSI
49.89
Rel Volume
0.08
Avg Volume
8.43K
Volume
644
Perf Week
1.83%
Perf Month
-0.28%
Perf Quarter
15.5%
Perf Half Y
10.21%
-
-
-
-
Beta
-0.211
-
-
Volatility
1.15%, 4.55%
Prev Close
1.12%
Price
72.3
Change
3.58%
BACTI-B.ST Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 5.55 | 5.14 | 4.84 | 6.38 | 5.75 | |
Net income per share | 0.49 | -1.14 | -1.68 | -1.51 | -3.95 | |
Operating cash flow per share | 1.62 | 0.02 | 0.21 | 0.09 | -1.49 | |
Free cash flow per share | 1.49 | -0.44 | 0 | -0.22 | -1.74 | |
Cash per share | 0.69 | 0.29 | 6.21 | 5.64 | 3.52 | |
Book value per share | 11.61 | 11.13 | 15.45 | 14.15 | 10.08 | |
Tangible book value per share | -1.82 | -2.41 | 3.28 | 2.83 | 3 | |
Share holders equity per share | 11.61 | 11.13 | 15.45 | 14.15 | 10.08 | |
Interest debt per share | 6.5 | 8.13 | 7.31 | 7.06 | 6.26 | |
Market cap | 2.75B | 4.8B | 5.78B | 3.87B | 2.17B | |
Enterprise value | 2.94B | 5.05B | 5.81B | 3.91B | 2.28B | |
P/E ratio | 169.22 | -124.95 | -98.38 | -73.17 | -15.65 | |
Price to sales ratio | 14.87 | 27.84 | 34.12 | 17.31 | 10.75 | |
POCF ratio | 50.96 | 6.83K | 796.89 | 1.26K | -41.38 | |
PFCF ratio | 55.51 | -327.47 | -152.16K | -492.47 | -35.54 | |
P/B Ratio | 7.11 | 12.85 | 10.68 | 7.8 | 6.13 | |
PTB ratio | 7.11 | 12.85 | 10.68 | 7.8 | 6.13 | |
EV to sales | 15.87 | 29.31 | 34.3 | 17.49 | 11.29 | |
Enterprise value over EBITDA | 48.14 | 225.09 | -770.09 | -2.05K | -27.16 | |
EV to operating cash flow | 54.38 | 7.2K | 801.08 | 1.28K | -43.48 | |
EV to free cash flow | 59.24 | -344.82 | -152.96K | -497.69 | -37.34 | |
Earnings yield | 0.01 | -0.01 | -0.01 | -0.01 | -0.06 | |
Free cash flow yield | 0.02 | 0 | 0 | 0 | -0.03 | |
Debt to equity | 0.54 | 0.71 | 0.46 | 0.48 | 0.54 | |
Debt to assets | 0.32 | 0.39 | 0.29 | 0.3 | 0.29 | |
Net debt to EBITDA | 3.03 | 11.33 | -4.02 | -21.53 | -1.31 | |
Current ratio | 0.57 | 3.13 | 5.15 | 3.66 | 0.76 | |
Interest coverage | 2.29 | -2.48 | -6.11 | -6.24 | -4.87 | |
Income quality | 3.32 | -0.02 | -0.12 | -0.06 | 0.38 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.24 | 0.29 | 0.33 | 0.37 | 0 | |
Research and developement to revenue | 0.14 | 0.16 | 0.18 | 0.14 | 0 | |
Intangibles to total assets | 0.7 | 0.67 | 0.5 | 0.49 | 0.37 | |
Capex to operating cash flow | -0.08 | -21.87 | -1.01 | -3.57 | 0.16 | |
Capex to revenue | -0.02 | -0.09 | -0.04 | -0.05 | -0.04 | |
Capex to depreciation | -0.1 | -0.35 | -0.16 | -0.22 | -0.15 | |
Stock based compensation to revenue | 0.03 | 0.04 | 0.03 | 0.03 | 0 | |
Graham number | 11.29 | 16.93 | 24.15 | 21.91 | 29.92 | |
ROIC | 0.05 | -0.03 | -0.06 | -0.06 | -0.22 | |
Return on tangible assets | 0.08 | -0.17 | -0.14 | -0.13 | -0.33 | |
Graham Net | -5.66 | -6.69 | -0.98 | -1.35 | -4.33 | |
Working capital | -72.09M | 75.73M | 258.13M | 224.15M | -63.28M | |
Tangible asset value | -60.46M | -80.72M | 114.83M | 99.09M | 105.1M | |
Net current asset value | -157.4M | -190.53M | 12.5M | -3.64M | -110.84M | |
Invested capital | 0.54 | 0.71 | 0.46 | 0.48 | 0.54 | |
Average receivables | 58.44M | 57.63M | 58.81M | 54.99M | 42.51M | |
Average payables | 7.82M | 8.69M | 18.35M | 30.86M | 25.26M | |
Average inventory | 14.31M | 24.26M | 35.11M | 40.22M | 37.01M | |
Days sales outstanding | 94.63 | 142.56 | 108.37 | 97.4 | 45.94 | |
Days payables outstanding | 97.77 | 91.28 | 263.29 | 284.33 | 17.86 | |
Days of inventory on hand | 163.37 | 354.29 | 340.29 | 373 | 31.72 | |
Receivables turnover | 3.86 | 2.56 | 3.37 | 3.75 | 7.95 | |
Payables turnover | 3.73 | 4 | 1.39 | 1.28 | 20.44 | |
Inventory turnover | 2.23 | 1.03 | 1.07 | 0.98 | 11.51 | |
ROE | 0.04 | -0.1 | -0.11 | -0.11 | -0.39 | |
Capex per share | -0.13 | -0.46 | -0.21 | -0.31 | -0.25 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 1.21 | 1.75 | 1.46 | 1.41 | 1.61 | |
Net income per share | -0.4 | -0.63 | -1.84 | -0.7 | -0.78 | |
Operating cash flow per share | 0.2 | -0.22 | -0.56 | -1 | 0.29 | |
Free cash flow per share | 0.12 | -0.25 | -0.58 | -1.02 | 0.08 | |
Cash per share | 5.64 | 5.33 | 4.66 | 3.55 | 3.52 | |
Book value per share | 14.15 | 13.5 | 11.64 | 10.95 | 10.08 | |
Tangible book value per share | 2.83 | 2.43 | 0.82 | 0.3 | 3 | |
Share holders equity per share | 14.15 | 13.5 | 11.64 | 10.95 | 10.08 | |
Interest debt per share | 6.66 | 7.07 | 6.99 | 6.92 | 5.75 | |
Market cap | 3.87B | 2.59B | 2.5B | 2.27B | 2.17B | |
Enterprise value | 3.91B | 2.65B | 2.58B | 2.39B | 2.28B | |
P/E ratio | -68.22 | -29.34 | -9.7 | -23.11 | -19.89 | |
Price to sales ratio | 91.59 | 42.4 | 48.88 | 45.96 | 38.5 | |
POCF ratio | 555.46 | -337.35 | -126.72 | -64.97 | 214.24 | |
PFCF ratio | 934.04 | -293.15 | -122.37 | -63.33 | 817.87 | |
P/B Ratio | 7.8 | 5.48 | 6.13 | 5.93 | 6.13 | |
PTB ratio | 7.8 | 5.48 | 6.13 | 5.93 | 6.13 | |
EV to sales | 92.56 | 43.31 | 50.36 | 48.21 | 40.45 | |
Enterprise value over EBITDA | 7.36K | -566.91 | -71.88 | -325.9 | -366.62 | |
EV to operating cash flow | 561.35 | -344.56 | -130.55 | -68.15 | 225.11 | |
EV to free cash flow | 943.94 | -299.41 | -126.08 | -66.44 | 859.36 | |
Earnings yield | 0 | -0.01 | -0.03 | -0.01 | -0.01 | |
Free cash flow yield | 0 | 0 | -0.01 | -0.02 | 0 | |
Debt to equity | 0.48 | 0.51 | 0.59 | 0.62 | 0.54 | |
Debt to assets | 0.3 | 0.31 | 0.33 | 0.34 | 0.29 | |
Net debt to EBITDA | 77.16 | -11.85 | -2.11 | -15.23 | -17.7 | |
Current ratio | 3.66 | 3.53 | 2.53 | 2.55 | 0.76 | |
Interest coverage | 4.21 | -3.32 | -11.92 | -3.28 | -2.4 | |
Income quality | -0.49 | 0.35 | 0.31 | 1.42 | -0.37 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.49 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0.31 | 0.1 | 0.12 | 0.13 | 0 | |
Intangibles to total assets | 0.49 | 0.49 | 0.52 | 0.53 | 0.37 | |
Capex to operating cash flow | -0.41 | 0.15 | 0.04 | 0.03 | -0.74 | |
Capex to revenue | -0.07 | -0.02 | -0.01 | -0.02 | -0.13 | |
Capex to depreciation | -0.13 | -0.12 | -0.03 | -0.12 | -0.38 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 11.35 | 13.84 | 21.95 | 13.15 | 13.27 | |
ROIC | -0.02 | -0.02 | -0.09 | -0.03 | -0.04 | |
Return on tangible assets | -0.03 | -0.06 | -0.18 | -0.08 | -0.07 | |
Graham Net | -1.35 | -1.93 | -3.1 | -4.08 | -4.33 | |
Working capital | 224.15M | 208.9M | 149.8M | 134.48M | -63.28M | |
Tangible asset value | 99.09M | 85.04M | 28.61M | 10.35M | 105.1M | |
Net current asset value | -3.64M | -20.95M | -78.57M | -94.8M | -110.84M | |
Invested capital | 0.48 | 0.51 | 0.59 | 0.62 | 0.54 | |
Average receivables | 64.24M | 54.05M | 48.46M | 42.77M | 31.22M | |
Average payables | 33.8M | 32.16M | 23.24M | 16.81M | 17.16M | |
Average inventory | 43.94M | 43.71M | 39.39M | 38.76M | 35.72M | |
Days sales outstanding | 127.11 | 71.3 | 85.21 | 67.44 | 40.59 | |
Days payables outstanding | 254.8 | 193.99 | 57.18 | 171.83 | 18.32 | |
Days of inventory on hand | 334.26 | 273.86 | 127.78 | 407.32 | 32.54 | |
Receivables turnover | 0.71 | 1.26 | 1.06 | 1.33 | 2.22 | |
Payables turnover | 0.35 | 0.46 | 1.57 | 0.52 | 4.91 | |
Inventory turnover | 0.27 | 0.33 | 0.7 | 0.22 | 2.77 | |
ROE | -0.03 | -0.05 | -0.16 | -0.06 | -0.08 | |
Capex per share | -0.08 | -0.03 | -0.02 | -0.03 | -0.21 |
BACTI-B.ST Frequently Asked Questions
What is Bactiguard Holding AB (publ) stock symbol ?
Bactiguard Holding AB (publ) is a SE stock and trading under the symbol BACTI-B.ST
What is Bactiguard Holding AB (publ) stock quote today ?
Bactiguard Holding AB (publ) stock price is $72.3 today.
Is Bactiguard Holding AB (publ) stock public?
Yes, Bactiguard Holding AB (publ) is a publicly traded company.